446 related articles for article (PubMed ID: 9630355)
21. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
Baurand A; Eckly A; Hechler B; Kauffenstein G; Galzi JL; Cazenave JP; Léon C; Gachet C
Mol Pharmacol; 2005 Mar; 67(3):721-33. PubMed ID: 15602005
[TBL] [Abstract][Full Text] [Related]
22. Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor.
Lages B; Weiss HJ
Thromb Haemost; 1997 Feb; 77(2):376-82. PubMed ID: 9157599
[TBL] [Abstract][Full Text] [Related]
23. Platelet activation by ADP: the role of ADP antagonists.
Gachet C
Ann Med; 2000 Dec; 32 Suppl 1():15-20. PubMed ID: 11209975
[TBL] [Abstract][Full Text] [Related]
24. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents.
Manolopoulos P; Glenn JR; Fox SC; May JA; Dovlatova NL; Tang SW; Thomas NR; Ralevic V; Heptinstall S
Platelets; 2008 Mar; 19(2):134-45. PubMed ID: 18297551
[TBL] [Abstract][Full Text] [Related]
25. Human Ntera-2/D1 neuronal progenitor cells endogenously express a functional P2Y1 receptor.
Moore DJ; Chambers JK; Murdock PR; Emson PC
Neuropharmacology; 2002 Nov; 43(6):966-78. PubMed ID: 12423666
[TBL] [Abstract][Full Text] [Related]
26. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
Rozalski M; Nocun M; Watala C
Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
[TBL] [Abstract][Full Text] [Related]
27. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
Hechler B; Léon C; Vial C; Vigne P; Frelin C; Cazenave JP; Gachet C
Blood; 1998 Jul; 92(1):152-9. PubMed ID: 9639511
[TBL] [Abstract][Full Text] [Related]
28. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
Tomé AR; Castro E; Santos RM; Rosário LM
BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
[TBL] [Abstract][Full Text] [Related]
29. Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells.
Marteau F; Communi D; Boeynaems JM; Suarez Gonzalez N
J Leukoc Biol; 2004 Oct; 76(4):796-803. PubMed ID: 15240747
[TBL] [Abstract][Full Text] [Related]
30. Selective stimulation of catecholamine release from bovine adrenal chromaffin cells by an ionotropic purinergic receptor sensitive to 2-methylthio ATP.
Tomé AR; Castro E; Santos RM; Rosário LM
BMC Neurosci; 2007 Jun; 8():41. PubMed ID: 17584495
[TBL] [Abstract][Full Text] [Related]
31. Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)-receptor.
Hoffmann K; Sixel U; Di Pasquale F; von Kügelgen I
Biochem Pharmacol; 2008 Nov; 76(10):1201-13. PubMed ID: 18809389
[TBL] [Abstract][Full Text] [Related]
32. ADP is not an agonist at P2X(1) receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets.
Mahaut-Smith MP; Ennion SJ; Rolf MG; Evans RJ
Br J Pharmacol; 2000 Sep; 131(1):108-14. PubMed ID: 10960076
[TBL] [Abstract][Full Text] [Related]
33. Role of intracellular signaling events in ADP-induced platelet aggregation.
Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
[TBL] [Abstract][Full Text] [Related]
34. Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.
Tulapurkar ME; Laubinger W; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2004 Jul; 142(5):869-78. PubMed ID: 15197109
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of purinergic inhibitory neuromuscular transmission in the human colon.
Gallego D; Gil V; Aleu J; Martinez-Cutillas M; Clavé P; Jimenez M
Neurogastroenterol Motil; 2011 Aug; 23(8):792-e338. PubMed ID: 21585621
[TBL] [Abstract][Full Text] [Related]
36. ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.
Kennedy C; Qi AD; Herold CL; Harden TK; Nicholas RA
Mol Pharmacol; 2000 May; 57(5):926-31. PubMed ID: 10779375
[TBL] [Abstract][Full Text] [Related]
37. Evidence that 2-methylthioATP and 2-methylthioADP are both agonists at the rat hepatocyte P2Y(1) receptor.
Dixon CJ
Br J Pharmacol; 2000 Jun; 130(3):664-8. PubMed ID: 10821796
[TBL] [Abstract][Full Text] [Related]
38. Modulation of platelet responses by 2-[3-(bromo-2-oxopropylthio)]adenosine-5'-diphosphate involves its binding to as well as covalent modification of an ADP-receptor, aggregin.
Puri RN; Colman RF; Colman RW
Arch Biochem Biophys; 1997 Jul; 343(1):140-5. PubMed ID: 9210656
[TBL] [Abstract][Full Text] [Related]
39. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
Kauffenstein G; Hechler B; Cazenave JP; Gachet C
J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
[TBL] [Abstract][Full Text] [Related]
40. An examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor.
Schachter JB; Harden TK
Br J Pharmacol; 1997 May; 121(2):338-44. PubMed ID: 9154346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
